Literature DB >> 14545894

Genetically engineering mammalian cell lines for increased viability and productivity.

D D Mosser1, B Massie.   

Abstract

The generation of new host cell lines for the production of foreign proteins can be achieved by cell engineering. This approach can be used to enhance the cell's ability to produce proteins that are properly processed and secreted at elevated levels and consequently can increase the overall productivity of an expression system. One potential target for cell engineering is the modification of the cell's protein folding capacity. The appropriate folding, assembly, localization and secretion of newly synthesized proteins is dependent upon the action of a group of proteins known as molecular chaperones. Improving the host cell's chaperoning capacity might increase the yield of properly folded recombinant proteins by preventing the formation of insoluble aggregates. Another potentially beneficial cell engineering goal is the inhibition of physiological cell death. The productivity of genetically engineered cells is dependent upon the maintenance of high levels of cell viability throughout the bioprocess period. Fluctuations in a cell's environment can trigger a deliberate form of cell death known as apoptosis. The proteins that mediate this self-destruction are currently being characterized. Regulating the expression of these death genes by cellular engineering could limit the loss of productivity that results from the physiological death of the recombinant cell line.

Entities:  

Year:  1994        PMID: 14545894     DOI: 10.1016/0734-9750(94)90013-2

Source DB:  PubMed          Journal:  Biotechnol Adv        ISSN: 0734-9750            Impact factor:   14.227


  5 in total

1.  Induction of apoptosis in oxygen-deprived cultures of hybridoma cells.

Authors:  S Mercille; B Massie
Journal:  Cytotechnology       Date:  1994       Impact factor: 2.058

2.  Bcl-2 inhibits apoptosis and extends recombinant protein production in cells infected with Sindbis viral vectors.

Authors:  A J Mastrangelo; J M Hardwick; M J Betenbaugh
Journal:  Cytotechnology       Date:  1996-01       Impact factor: 2.058

3.  Apoptosis-resistant NS/0 E1B-19K myelomas exhibit increased viability and chimeric antibody productivity under cell cycle modulating conditions.

Authors:  S Mercille; B Massie
Journal:  Cytotechnology       Date:  1998-11       Impact factor: 2.058

4.  Prolongation of murine hybridoma cell survival in stationary batch culture by Bcl-xL expression.

Authors:  J R Charbonneau; E R Gauthier
Journal:  Cytotechnology       Date:  2000-10       Impact factor: 2.058

5.  Serum-free transient protein production system based on adenoviral vector and PER.C6 technology: high yield and preserved bioactivity.

Authors:  M J E Havenga; L Holterman; I Melis; S Smits; J Kaspers; E Heemskerk; R van der Vlugt; M Koldijk; G J Schouten; G Hateboer; K Brouwer; R Vogels; J Goudsmit
Journal:  Biotechnol Bioeng       Date:  2008-06-01       Impact factor: 4.530

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.